Literature DB >> 32514908

The use of survivorship care plans by female racial and ethnic minority breast cancer survivors: a systematic review.

Marquita W Lewis-Thames1,2, Shaila M Strayhorn3, Yamilé Molina4,5, Timiya S Nolan6.   

Abstract

PURPOSE: Racial/ethnic breast cancer survivorship disparities persist as minority breast cancer survivors (MBCSs) report fragmentation in survivorship care, namely in the access and delivery of survivorship care plans (SCPs). To better understand care coordination of MCBS, this review elucidated concerns of female MBCS about their preparation for post-treatment survivorship care, the preferred practices for the delivery of a SCP, and the associated content to improve post-treatment survivorship care understanding.
METHODS: A systematic search of articles from PubMed, Ovid-Medline, CINAHL databases, and bibliographic reviews included manuscripts using keywords for racial/ethnic minority groups and breast cancer survivorship care coordination terms. Salient themes and article quality were analyzed from the extracted data.
RESULTS: Fourteen included studies represented 5,854 participants and over 12 racial/ethnic groups. The following themes of post-treatment MBCS were identified from the review: (1) uncertainty about post-treatment survivorship care management is a consequence of sub-optimal patient-provider communication; (2) access to SCPs and related materials are desired, but sporadic; and (3) advancements to the delivery and presentation of SCPs and related materials are desired.
CONCLUSIONS: Representation of only 14 studies indicates that the MBCSs' perspective post-treatment survivorship care is underrepresented in the literature. Themes from this review support access to, and implementation of, culturally tailored SCP for MBCS. There was multi-ethnic acceptance of SCPs as a tool to help improve care coordination. IMPLICATIONS FOR CANCER SURVIVORS: These findings highlight the importance of general education about post-treatment survivorship, post-treatment survivorship needs identification, and the elucidation of gaps in effective SCP delivery among MBCS.

Entities:  

Keywords:  Breast cancer; Care planning; Long-term cancer survivors; Minority health; Survivorship care plans

Mesh:

Year:  2020        PMID: 32514908      PMCID: PMC8863542          DOI: 10.1007/s11764-020-00894-8

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  74 in total

1.  Racial/ethnic disparities in time to follow-up after an abnormal mammogram.

Authors:  Rebecca Press; Olveen Carrasquillo; Robert R Sciacca; Elsa-Grace V Giardina
Journal:  J Womens Health (Larchmt)       Date:  2008 Jul-Aug       Impact factor: 2.681

Review 2.  An overview of the unique challenges facing African-American breast cancer survivors.

Authors:  Marium Husain; Timiya S Nolan; Kevin Foy; Raquel Reinbolt; Cassandra Grenade; Maryam Lustberg
Journal:  Support Care Cancer       Date:  2018-11-20       Impact factor: 3.603

Review 3.  Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes.

Authors:  Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber
Journal:  Oncologist       Date:  2019-10-25

4.  Primary Care Practitioners' Perceptions of Electronic Consult Systems: A Qualitative Analysis.

Authors:  Michelle S Lee; Kristin N Ray; Ateev Mehrotra; Paul Giboney; Hal F Yee; Michael L Barnett
Journal:  JAMA Intern Med       Date:  2018-06-01       Impact factor: 21.873

5.  Ethnic disparities in adherence to breast cancer survivorship surveillance care.

Authors:  Pragati S Advani; Jun Ying; Richard Theriault; Amal Melhem-Bertrand; Stacy Moulder; Isabelle Bedrosian; Welela Tereffe; Shon Black; Tunghi May Pini; Abenaa M Brewster
Journal:  Cancer       Date:  2013-11-20       Impact factor: 6.860

Review 6.  Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy.

Authors:  Larissa Nekhlyudov; Michelle A Mollica; Paul B Jacobsen; Deborah K Mayer; Lawrence N Shulman; Ann M Geiger
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

7.  A culturally adapted survivorship programme for Asian early stage breast cancer patients in Singapore: A randomized, controlled trial.

Authors:  Alexandre Chan; Yan Xiang Gan; Suan Kai Oh; Terence Ng; Maung Shwe; Raymond Chan; Raymond Ng; Brandon Goh; Yee Pin Tan; Gilbert Fan
Journal:  Psychooncology       Date:  2017-01-25       Impact factor: 3.894

8.  Health information needs and preferences in relation to survivorship care plans of long-term cancer survivors in the American Cancer Society's Study of Cancer Survivors-I.

Authors:  Mary Playdon; Leah M Ferrucci; Ruth McCorkle; Kevin D Stein; Rachel Cannady; Tara Sanft; Brenda Cartmel
Journal:  J Cancer Surviv       Date:  2016-01-07       Impact factor: 4.442

9.  A community effort to reduce the black/white breast cancer mortality disparity in Chicago.

Authors:  David Ansell; Paula Grabler; Steven Whitman; Carol Ferrans; Jacqueline Burgess-Bishop; Linda Rae Murray; Ruta Rao; Elizabeth Marcus
Journal:  Cancer Causes Control       Date:  2009-08-18       Impact factor: 2.506

10.  Publicly available apps for cancer survivors: a scoping review.

Authors:  Rosalind Adam; Drew McMichael; Daniel Powell; Peter Murchie
Journal:  BMJ Open       Date:  2019-09-30       Impact factor: 2.692

View more
  2 in total

Review 1.  Update to 2019-2022 ONS Research Agenda: Rapid Review to Address Structural Racism and Health Inequities.

Authors:  Randy A Jones; Rachel Hirschey; Grace Campbell; Mary E Cooley; Darryl Somayaji; Robin Lally; Erik K Rueter; Mary Magee Gullatte
Journal:  Oncol Nurs Forum       Date:  2021-11-01       Impact factor: 2.172

Review 2.  Survivorship Care Plan Preferences and Utilization Among Asian American Breast Cancer Survivors.

Authors:  Timiya S Nolan; Elizabeth Arthur; Ogechi Nwodim; Amelia Spaulding; Jennifer Kue
Journal:  Oncol Nurs Forum       Date:  2021-09-01       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.